download center

Information

Temos Introduction

Temos Corporate Broschure

Temos Accreditation Process in Steps

Temos Code of Ethics 

Temos COVID-19 Safe Brochure (English)

Temos COVID-19 Safe Brochure (Spain)

Temos COVID-19 Safe Brochure (Greek)

Temos Dental Brochure (English)

Temos Dental Brochure (Spanish)

Temos Reproductive Brochure (English)

Temos Reproductive Brochure (Spanish)

Temos Pharmacy Brochure

Temos Facilitator Brochure (English)

Temos Facilitator Brochure (Spanish)

Temos Latest Newsletter

Temos News

Get started!

Our team is ready to help you discover the best program for your organization.
To get started, click here to set up a free account. Contact us now: +49 2204 426480 or e-mail.
Click here to see the overview of the accreditation process.

Press

Press release "COVID-19 Safe" program English

Press release "COVID-19 Safe" program Spanish

Press release "COVID-19 Safe" program German

Press release "COVID-19 Safe" program Greek

Press release "IAG cooperation with Temos" English

Press release "IAG cooperation with Temos" German

Press release "IAG cooperation with Temos" Spanish

Press release "IAG cooperation with Temos" Greek

Press release "Community Pharmacy Services" English

Press release "Community Pharmacy Services" German

Press release "Community Pharmacy Services" Greek

Press release "ISQua accredite dental care programs_English"

Press release "ISQua accredite medical care programs_German"

Press release "ISQua accredite medical care programs_Spanish"

Press release "ISQua accredite medical care programs_Greek"

Press release "ISQua accredite medical care programs_English"

Press release "ISQua accredite medical care programs_German"

Legal

Temos Data Privacy Statement

Temos Terms & Conditions

Temos Terms & Conditions for Medical Travel Providers

Temos Terms & Conditions for Community Pharmacy Services

Temos Terms & Conditions for Certificate of Compliance "COVID-19 Safe"

Follow us and keep updated 

Keep informed about Temos International's news and events by subscribing to our newsletter and following us on Facebook, LinkedIn, and Twitter.